ACM

ADAR1 Capital Management Portfolio holdings

AUM $1.66B
1-Year Est. Return 340.85%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+340.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.66B
AUM Growth
+$327M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
329
New
Increased
Reduced
Closed

Top Buys

1
+$40.1M
2
+$37.1M
3
+$36.2M
4
INSP icon
Inspire Medical Systems
INSP
+$27.3M
5
VIR icon
Vir Biotechnology
VIR
+$21.9M

Top Sells

1
+$39.4M
2
+$17.3M
3
+$13.2M
4
FULC icon
Fulcrum Therapeutics
FULC
+$10.4M
5
ABUS icon
Arbutus Biopharma
ABUS
+$9.98M

Sector Composition

1 Healthcare 90.27%
2 Financials 1.54%
3 Technology 0.08%
4 Industrials 0.08%
5 Materials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMEA icon
276
Biomea Fusion
BMEA
$99.8M
$66.4K ﹤0.01%
43,420
NMRA icon
277
Neumora Therapeutics
NMRA
$343M
$64.5K ﹤0.01%
33,100
-17,500
OGN icon
278
Organon & Co
OGN
$3.5B
$59.9K ﹤0.01%
10,000
-25,000
ESPR icon
279
Esperion Therapeutics
ESPR
$806M
$58.6K ﹤0.01%
+21,400
MREO
280
Mereo BioPharma
MREO
$54.9M
$49.5K ﹤0.01%
150,000
ANTX icon
281
AN2 Therapeutics
ANTX
$156M
$47.4K ﹤0.01%
+13,861
ASPCR
282
A SPAC III Acquisition Corp Right
ASPCR
$42.4K ﹤0.01%
215,000
AQST icon
283
Aquestive Therapeutics
AQST
$504M
$41.5K ﹤0.01%
+10,000
ATYR
284
aTyr Pharma
ATYR
$53.2M
$39.5K ﹤0.01%
50,685
BCAB icon
285
BioAtla
BCAB
$6.51M
$36.7K ﹤0.01%
4,562
+900
KALA icon
286
KALA BIO
KALA
$41.5M
$24.5K ﹤0.01%
2,830
CHRS icon
287
Coherus Oncology
CHRS
$245M
$17.5K ﹤0.01%
10,366
PRQR icon
288
ProQR Therapeutics
PRQR
$166M
$16.2K ﹤0.01%
10,000
QNCX icon
289
Quince Therapeutics
QNCX
$22.5M
$5.08K ﹤0.01%
5,010
+719
IOBT
290
DELISTED
IO Biotech
IOBT
– –
-24,964
IWM icon
291
iShares Russell 2000 ETF
IWM
$79.4B
– –
-12,070
KVAC icon
292
Keen Vision Acquisition Corp
KVAC
$67.5M
– –
0
LQDA icon
293
Liquidia Corp
LQDA
$5.5B
– –
0
RNAM
294
DELISTED
Avidity Biosciences
RNAM
– –
-546,534
SABS icon
295
SAB Biotherapeutics
SABS
$275M
– –
-26,344
SPRO icon
296
Spero Therapeutics
SPRO
$164M
– –
-113,839
UTHR icon
297
United Therapeutics
UTHR
$23.6B
– –
-1,900
STI icon
298
Solidion Technology
STI
$36M
– –
0
ATXS
299
DELISTED
Astria Therapeutics
ATXS
– –
-173,557
AUPH icon
300
Aurinia Pharmaceuticals
AUPH
$1.97B
– –
-22,000
9 10 11
12
13